journal article·2017-05Open access

Nano-suspension coating as a technique to modulate the drug release from controlled porosity osmotic pumps for a soluble agent

Leila Azharshekoufeh Bahari, Yousef Javadzadeh, Mohammad Barzegar Jalali, Peyvand Johari, Ali Nokhodchi, Javad Shokri

Abstract

In controlled porosity osmotic pumps (CPOP), usually finding a single solvent with a capability to dissolve both film former (hydrophobic) and pore former (hydrophilic) is extremely challenging. Therefore, the aim of the present investigation was to tackle the issue associated with controlled porosity osmotic pump (CPOP) system using nano-suspension coating method. In the present study 4-Amino pyridine was used as a highly water soluble drug. In this method, a hydrophilic pore former (sucrose or mannitol) in nano range was suspended in polymeric coating solution using ball-mill. The performance of the prepared formulations was assessed in terms of D12h (cumulative release percent after 12h), Devzero (mean percent deviation of drug release from zero order kinetic), tL (lag time of the drug release) and RSQzero. The results revealed that gelling agent amount (HPMC E15LV) in core and pore former concentration in SPM had crucial effect on SPM integrity. All the optimised formulations showed a burst drug release due to fast dissolving nature of the pore formers. Results obtained from scanning electron microscopy demonstrated the formation of nanopores in the membrane where the drug release takes place via these nanopores. Nano suspension coating method can be introduced as novel method in formulation of CPOPs.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Microfluidic and Capillary Electrophoresis Applications · Advanced Drug Delivery Systems · Drug Solubulity and Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (30)

Show source-provided references
1. Economic aspects of controlled drug delivery
2. Verma · Drug Dev. Ind. Pharm. · 2000 · 26 · 69510.1081/DDC-100101287 ↗
3. Verma · J. Controlled Release · 2002 · 79 · 710.1016/S0168-3659(01)00550-8 ↗
4. Shokri · Drug Res. · 2013 · 63 · 41410.1055/s-0033-1343429 ↗
5. Theeuwes · J. Pharm. Sci. · 1975 · 64 · 198710.1002/jps.2600641218 ↗
6. Gong · Drug Dev. Ind. Pharm. · 2015 · 41 · 46410.3109/03639045.2013.877923 ↗
7. Mathu · Int. J. Pharm. Sci. Res. · 2016 · 7 · 453
8. Liu · J. Controlled Release · 2000 · 68 · 14510.1016/S0168-3659(00)00243-1 ↗
9. Zhang · Int. J. Pharm. · 2011 · 410 · 4110.1016/j.ijpharm.2011.03.013 ↗
10. Malaterre · Int. J. Pharm. · 2009 · 376 · 5610.1016/j.ijpharm.2009.04.015 ↗
11. Shokri · Pharm. Sci. · 2004 · 1 · 75
12. Yang · Int. J. Pharm. · 2016 · 506 · 34010.1016/j.ijpharm.2016.04.061 ↗
13. Thakkar · AAPS PharmSciTech · 2015 · 17 · 1
14. Sahoo · 2015 · 53 · 195
15. A.A. McKinney, G.D. Tollefson, E. Weber, R. Soltero, US Patents 20130177602 A1, 2012.
16. Jain · World J. · 2014
17. Thombre · J. Controlled Release · 2004 · 94 · 7510.1016/j.jconrel.2003.09.009 ↗
18. Shokri · Eur. J. Pharm. Biopharm. · 2008 · 68 · 28910.1016/j.ejpb.2007.06.006 ↗
19. Nokhodchi · Drug Deliv. · 2008 · 15 · 4310.1080/10717540701829028 ↗
20. F. Theeuwes, R.J. Saunders, W.S. Mefford, Process for forming outlet passageways in pills using a laser. US patent 4088864 A, 1978.
21. Makhija · J. Controlled Release · 2003 · 89 · 510.1016/S0168-3659(02)00482-0 ↗
22. Kanagale · AAPS PharmSciTech · 2007 · 810.1208/pt0803053 ↗
23. Abd-Elbary · AAPS PharmSciTech · 2011 · 12 · 48510.1208/s12249-011-9608-z ↗
24. Keraliya · lISRN Pharm. · 2012 · 1
25. Cellulose-Medical, Pharmaceutical and Electronic Applications
26. Adibkia · Drug Res. · 2014 · 64 · 203
27. Zentner · J. Controlled Release · 1985 · 1 · 26910.1016/0168-3659(85)90003-3 ↗
28. Thombre · J. Membr. Sci. · 1989 · 40 · 27910.1016/S0376-7388(00)81152-7 ↗
29. Sharma · AAPS PharmSciTech · 2005 · 6 · 61810.1208/pt060476 ↗
30. Hirvonen · Dosis · 2008 · 24 · 129